BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 21962566)

  • 1. Association between serotonin transporter gene promoter-region polymorphism and 4- and 12-week treatment response to sertraline in posttraumatic stress disorder.
    Mushtaq D; Ali A; Margoob MA; Murtaza I; Andrade C
    J Affect Disord; 2012 Feb; 136(3):955-62. PubMed ID: 21962566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice.
    Shiner B; Westgate CL; Gui J; Maguen S; Young-Xu Y; Schnurr PP; Watts BV
    J Clin Psychiatry; 2018 Sep; 79(5):. PubMed ID: 30257081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone growth in juvenile rhesus monkeys is influenced by 5HTTLPR polymorphisms and interactions between 5HTTLPR polymorphisms and fluoxetine.
    Golub MS; Bulleri AM; Hogrefe CE; Sherwood RJ
    Bone; 2015 Oct; 79():162-9. PubMed ID: 26067181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of 5-HTTLPR polymorphism on postpartum depressive and posttraumatic symptoms.
    Landoni M; Missaglia S; Tavian D; Ionio C; Di Blasio P
    Psychiatr Genet; 2022 Feb; 32(1):9-14. PubMed ID: 34694246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorder.
    Parmenter ME; Lederman S; Weathers FW; Davis LL; Vaughn B; Engels J; Sullivan GM
    Psychiatry Res; 2024 Apr; 334():115764. PubMed ID: 38350291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of 5-HTTLPR With Post-Traumatic Stress Disorder in US Service Members.
    Hu XZ; Ursano RJ; Benedek D; Li X; ; Zhang L
    Chronic Stress (Thousand Oaks); 2024; 8():24705470241245497. PubMed ID: 38682050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To Predict, Prevent, and Manage Post-Traumatic Stress Disorder (PTSD): A Review of Pathophysiology, Treatment, and Biomarkers.
    Al Jowf GI; Ahmed ZT; Reijnders RA; de Nijs L; Eijssen LMT
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Public Health Perspective of Post-Traumatic Stress Disorder.
    Al Jowf GI; Ahmed ZT; An N; Reijnders RA; Ambrosino E; Rutten BPF; de Nijs L; Eijssen LMT
    Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Molecular Biology of Susceptibility to Post-Traumatic Stress Disorder: Highlights of Epigenetics and Epigenomics.
    Al Jowf GI; Snijders C; Rutten BPF; de Nijs L; Eijssen LMT
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rodent models of post-traumatic stress disorder: behavioral assessment.
    Verbitsky A; Dopfel D; Zhang N
    Transl Psychiatry; 2020 May; 10(1):132. PubMed ID: 32376819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PharmGKB summary: sertraline pathway, pharmacokinetics.
    Huddart R; Hicks JK; Ramsey LB; Strawn JR; Smith DM; Bobonis Babilonia M; Altman RB; Klein TE
    Pharmacogenet Genomics; 2020 Feb; 30(2):26-33. PubMed ID: 31851125
    [No Abstract]   [Full Text] [Related]  

  • 12. Translating Molecular and Neuroendocrine Findings in Posttraumatic Stress Disorder and Resilience to Novel Therapies.
    DePierro J; Lepow L; Feder A; Yehuda R
    Biol Psychiatry; 2019 Sep; 86(6):454-463. PubMed ID: 31466562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models of PTSD: a challenge to be met.
    Richter-Levin G; Stork O; Schmidt MV
    Mol Psychiatry; 2019 Aug; 24(8):1135-1156. PubMed ID: 30816289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural and psychological characteristics of college students with alcoholic parents differ depending on current alcohol use.
    Brown-Rice KA; Scholl JL; Fercho KA; Pearson K; Kallsen NA; Davies GE; Ehli EA; Olson S; Schweinle A; Baugh LA; Forster GL
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():284-296. PubMed ID: 28939188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological predictors of pharmacological therapy in anxiety disorders.
    Maron E; Nutt D
    Dialogues Clin Neurosci; 2015 Sep; 17(3):305-17. PubMed ID: 26487811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of PTSD treatment on the cortisol awakening response.
    Pacella ML; Feeny N; Zoellner L; Delahanty DL
    Depress Anxiety; 2014 Oct; 31(10):862-9. PubMed ID: 25327949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the 5-HTTLPR polymorphism on posttraumatic stress disorder, depression, anxiety, and quality of life among Iraq and Afghanistan veterans.
    Kimbrel NA; Morissette SB; Meyer EC; Chrestman R; Jamroz R; Silvia PJ; Beckham JC; Young KA
    Anxiety Stress Coping; 2015; 28(4):456-66. PubMed ID: 25314020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in posttraumatic stress disorder: overview and implications for future research.
    Schmidt U; Kaltwasser SF; Wotjak CT
    Dis Markers; 2013; 35(1):43-54. PubMed ID: 24167348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analyses of the 5-HTTLPR polymorphisms and post-traumatic stress disorder.
    Navarro-Mateu F; Escámez T; Koenen KC; Alonso J; Sánchez-Meca J
    PLoS One; 2013; 8(6):e66227. PubMed ID: 23825531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first steps on the path toward genomic predictors of behavioral therapy for posttraumatic stress disorder.
    Enoch MA
    Biol Psychiatry; 2013 Jun; 73(11):1039-40. PubMed ID: 23647733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.